Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Optimer Pharmaceuticals, Inc.    OPTR   US68401H1041

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
News SummaryMost relevantAll news 

Optimer Pharmaceuticals, Inc. : Daily Commentary & Trend Reports For: (NASDAQ: OPTR), (NASDAQ: SPCHB)

04/02/2013 | 01:55pm US/Eastern

New York (April 2nd, 2013) - Optimer Pharmaceuticals Inc. (NASDAQ: OPTR) shows bullish trend as the stock made a sharp movement in its latest trading session. It opened the session at $11.80 and remained in $11.80 and $14.48 price range during the session. The stock is 19.97 percent higher at $14.00. Optimer Pharmaceuticals’ first support level is at $13.50. Upon breaching this level, the stock may go as low as $13.25. On the upside, its first resistance level is at $14.35. The stock is up with very heavy volume of 2.781 million shares, confirming bullish trend.

Optimer Pharmaceuticals is rumored to be takeover target for various pharma companies including Glaxo.

Find out where OPTR could be headed by getting the free and full trend analysis report here:

http://www.monstertradingalerts.com/market-scan/?symbol=OPTR


Sport Chalet Inc. (NASDAQ: SPCHB) is trading in the range of $1.44 and $1.51during its latest trading session. The stock recorded the volume of 500 shares. Sport Chalet shows bullish trend, which is further confirmed by its MACD and EMA charts. The stock opened at $1.44 and is at $1.51, up 13.44 percent from its previous close of $1.33. It has its first support level at $1.48. Upon breaching this level, the stock may touch $1.35. In the intermediate time period, the stock may test $1.65 resistance level.

Sport Chalet operates specialty sporting goods stores and it is operational in the United States.

Get the latest trend analysis reports on SPCHB here:

http://www.monstertradingalerts.com/market-scan/?symbol=SPCHB

ABOUT US:

MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.MonsterTradingAlerts.com

Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit; http://www.monstertradingalerts.com/disclaimer/

Contact Info:
Alexander K. Neumann
Monster Trading Alerts
info@MonsterTradingAlerts.com
347-905-5009


© Accesswire 2013
Latest news on OPTIMER PHARMACEUTICALS, I
2013 OPTIMER PHARMACEUTICALS, INC. : Pre-Market Analysis: Inovio Pharmaceuticals Inc...
2013 OPTIMER PHARMACEUTICALS, INC. : Today's Research: Inovio Pharmaceuticals Inc., O..
2013 OPTIMER PHARMACEUTICALS, INC. : Harwood Feffer LLP Announces Investigation of Op..
2013 OPTIMER PHARMACEUTICALS, INC. : SHAREHOLDER ALERT: Law Office of Brodsky & Smith..
2013 OPTIMER PHARMACEUTICALS, INC. : Laboratory Permits, Pending FDA Approvals, Clini..
2013 OPTIMER PHARMACEUTICALS, INC. : SHAREHOLDER ALERT: Law Office of Brodsky & Smith..
2013 OPTIMER PHARMACEUTICALS, INC. : OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi..
2013 OPTIMER PHARMACEUTICALS, INC. : Ryan & Maniskas, LLP Announces Investigation of ..
2013 OPTIMER PHARMACEUTICALS, INC. : Optimer Reports Second Quarter 2013 Financial Re..
2013 OPTIMER PHARMACEUTICALS, INC. : Faruqi & Faruqi, LLP, Partner Juan E. Monteverde..
Advertisement
Chart
Duration : Period :
Optimer Pharmaceuticals, I Technical Analysis Chart | OPTR | US68401H1041 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF